PMDA’s Vision for Horizon Scanning of Emerging Technologies Potentially Relevant to the Development of New Medical Products: The Regulatory Challenge-Reference-Cited by-同舟云学术

PMDA’s Vision for Horizon Scanning of Emerging Technologies Potentially Relevant to the Development of New Medical Products: The Regulatory Challenge

Published:2020-08-18 Issue:2 Volume:109 Page:295-298
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Shimokawa Masafumi¹,Sato Daisaku²,Wakao Rika²,Arai Hiroyuki²

Affiliation:

1. Faculty of Pharmaceutical Sciences Sanyo‐Onoda City University Yamaguchi Japan

2. Center for Regulatory SciencePharmaceuticals and Medical Devices Agency Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1986

Reference11 articles.

1. New Governmental Regulatory System for Stem Cell—Based Therapies in Japan

2. International Coalition of Medicines Regulatory Authorities (ICMRA).Strategic Priority on Innovation – Final Report and Statement (2019). Accessed February 26 2020.

3. Regulatory Science and Innovation Programme for Europe (ReScIPE): a proposed model;Hines P. A.;Br. J. Clin. Pharmacol.

4. The Science Board.Pharmaceuticals and Medical Devices Agency (PMDA) (2012). Accessed February 26 2020.

5. Evolving Vision of Regulatory Science in the Global Medical Community

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products;Frontiers in Medicine;2024-01-11

2. Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities;Frontiers in Public Health;2023-05-04

3. In vivo CAR T cells and targeted gene delivery: A theme for the Pharmaceuticals and Medical Devices Agency Science Board to address;Frontiers in Medicine;2023-04-17

4. Future directions in regulatory affairs;Frontiers in Medicine;2023-01-09

5. Identification of Novel Modalities Through Bibliometric Analysis for Timely Development of Regulatory Guidance: A Case Study of T Cell Immunity;Frontiers in Medicine;2021-10-11